Since this topic was last reviewed rapid advances have been made in our understanding of inherited metabolic disease.' Much of this increased knowledge has been stimulated by the application of molecular genetic techniques to the study of human disease. In addition clarification of the function of various subcellular organelles has led to the recognition of a number of new disease states.
An aggressive approach to diagnosis and treatment remains the correct therapeutic option. The widespread availability of accurate imaging equipment and the advances in electrophysiological techniques have improved our ability to provide an early, accurate prognosis for most affected infants.
Despite our increased understanding of the pathophysiology of inherited metabolic disease the long term prognosis for many disorders remains poor, especially in those infants where there is a significant delay between the onset of symptoms and diagnosis and treatment. Arteriovenous haemoperfusion is being increasingly used as the method of choice for removal of toxic intermediary compounds and peritoneal dialysis is reserved for those infants in whom vascular access is not possible.
It is essential that the basic 'metabolic screen' is supplemented by a sample of blood (collected in a 5 ml EDTA tube) for subsequent DNA analysis. This is particularly important for infants suspected of having medium chain fatty acyl CoA dehydrogenase deficiency (MCAD) where analysis for the common mutation is often the quickest method of establishing the diagnosis and will detect 90% of cases within the white population. 2 Management of a child with an inborn error of metabolism while awaiting results is still based on attempts to rapidly induce an anabolic state. Glucose and insulin and the use of lipid emulsions remain the major therapeutic thrust during this period, supplemented by arteriovenous haemoperfusion. The 'blunderbuss' approach to treatment using a megavitamin cocktail can no longer be routinely recommended. Specific vitamin treatment after diagnosis of a disorder known to be vitamin responsive is appropriate.
The necropsy remains important in those infants for whom a diagnosis has not been found. In addition to blood, urine, cerebrospinal fluid, and skin fibroblasts, a muscle biopsy specimen should be collected and snap frozen. Muscle tissue is essential if a mitochondrial cytopathy is thought to be responsible for the infant's illness. of metabolism--an update.
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